Heart Disease News and Research

Latest Heart Disease News and Research

ATS develops clinical practice guidelines to help clinicians identify, manage patients with sickle cell disease

The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension.

18 Mar 2014

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for "proliferating infantile hemangioma requiring systemic therapy".

18 Mar 2014

Prehypertension bodes ill for stroke risk

A meta-analysis confirms that having blood pressure at the upper end of the normal range increases people’s risk of a stroke.

17 Mar 2014

Residual depression has lasting impact on bipolar patients

A prospective study confirms the detrimental effect of subthreshold depressive symptoms on the outcomes of patients with bipolar disorder.

17 Mar 2014

Research on diverse health benefits of oats in protecting heart

Eleven top scientists from around the globe presented the latest findings on the powerful compounds found in oats in a scientific session titled, Physicochemical Properties and Biological Functionality of Oats, at the 247th Annual Conference of the American Chemical Society in Dallas, TX

17 Mar 2014

State highlights: Wash. state cost and quality bills; Okla. privatized Medicaid; Fla. malpractice law overturned

...

17 Mar 2014

Researchers develop new software to aid cardiovascular risk diagnosis based on fundus image processing

Researchers from the Universitat Politècnica de València, the Hospital General de Valencia and the Ophthalmology Unit of the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (FISABIO-Oftalmología Médica) have developed a new software to aid cardiovascular risk diagnosis based on fundus image processing.

17 Mar 2014

Study suggests that non-communicable diseases can be programmed before birth

A new study in mothers and children of Pakistani origin suggests non-communicable diseases such as cardiovascular disease and Type 2 Diabetes could be programmed prior to birth.

17 Mar 2014

TVM Capital Healthcare Partners signs affiliation with Joslin Diabetes Center

TVM Capital Healthcare Partners, the region's first private equity firm dedicated exclusively to the healthcare sector, has signed an affiliation with Joslin Diabetes Center.

17 Mar 2014

Study shows correlation between blood poisoning and risk of blood clots

Every year, almost 10,000 Danes are admitted to hospital with blood poisoning, while more than 3,000 patients become infected while they are hospitalised. New research shows that Danes suffering from blood poisoning risk an extra challenge in the form of an increased risk of suffering a blood clot:

17 Mar 2014

Researchers present science and engineering research in Parliament

Two researchers from the University of Hertfordshire are attending Parliament to present their science to a range of politicians and a panel of expert judges as part of SET for Britain on Monday 17th March.

17 Mar 2014

Researchers create statistical model to predict whether heart scans are useful in prescribing statins

As long as inexpensive statins, which lower cholesterol, are readily available and patients don't mind taking them, it doesn't make sense to do a heart scan to measure how much plaque has built up in a patient's coronary arteries before prescribing the pills, according to a new study by researchers at UC San Francisco.

17 Mar 2014

Surgeons perform first auditory brainstem implant operation in Northeast Ohio

Surgeons at University Hospitals Case Medical Center have completed the first auditory brainstem implant (ABI) operation in Northeast Ohio on a woman who has lost most of her hearing due to benign tumors on her auditory nerves.

17 Mar 2014

FDA grants Fast Track designation to Edison’s lead drug EPI-743

Edison Pharmaceuticals today announced that the United States Food and Drug Administration granted Fast Track designation to EPI-743, the company's lead drug, for the treatment of Friedreich's ataxia. EPI-743 is being developed for pediatric and adult mitochondrial disease, including Friedreich's ataxia.

17 Mar 2014

Obama administration rule raises more questions about the individual mandate's reach

News outlets report that a hardship exemption was added that could potentially make it much easier for people to get around the requirement that they have health insurance.

17 Mar 2014

Scientists discover gene variation that makes humans have healthier blood lipid levels, reduced risk of heart attacks

Scientists have discovered a previously unrecognized gene variation that makes humans have healthier blood lipid levels and reduced risk of heart attacks -- a finding that opens the door to using this knowledge in testing or treatment of high cholesterol and other lipid disorders.

17 Mar 2014

Researchers discover certain proteins in osteoclasts that may be used to destroy cardiovascular calcification

Cardiovascular calcification (deposits of minerals in heart valves and blood vessels) is a primary contributor to heart disease, the leading cause of death among both men and women in the United States according the Centers for Disease Control and Prevention (CDC).

17 Mar 2014

Class, ancestry and medication are factors in cardiac risk for lupus patients

New research published in Rheumatology, the international, peer-reviewed scientific journal, has suggested that systemic lupus erythematosus (SLE) patients of African descent and from lower socioeconomic groups face a higher risk of primary cardiac disease. However, those taking anti-malarial drugs reduce their risk.

16 Mar 2014

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.

16 Mar 2014

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.

16 Mar 2014

Heart Disease News and Research

Latest Heart Disease News and Research

ATS develops clinical practice guidelines to help clinicians identify, manage patients with sickle cell disease

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Prehypertension bodes ill for stroke risk

Residual depression has lasting impact on bipolar patients

Research on diverse health benefits of oats in protecting heart

State highlights: Wash. state cost and quality bills; Okla. privatized Medicaid; Fla. malpractice law overturned

Researchers develop new software to aid cardiovascular risk diagnosis based on fundus image processing

Study suggests that non-communicable diseases can be programmed before birth

TVM Capital Healthcare Partners signs affiliation with Joslin Diabetes Center

Study shows correlation between blood poisoning and risk of blood clots

Researchers present science and engineering research in Parliament

Researchers create statistical model to predict whether heart scans are useful in prescribing statins

Surgeons perform first auditory brainstem implant operation in Northeast Ohio

FDA grants Fast Track designation to Edison’s lead drug EPI-743

Obama administration rule raises more questions about the individual mandate's reach

Scientists discover gene variation that makes humans have healthier blood lipid levels, reduced risk of heart attacks

Researchers discover certain proteins in osteoclasts that may be used to destroy cardiovascular calcification

Class, ancestry and medication are factors in cardiac risk for lupus patients

Merck's NOXAFIL injection gets FDA approval for intravenous use

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Heart Disease News and Research

Latest Heart Disease News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in